GeekGene Biotechnology
- Biotech or pharma, therapeutic R&D
We are an innovative cell therapy company that integrates high-throughput single cell omics data with chemical reprogramming to regulate cell fate. Our current focus is on developing high-quality T-cell therapies for treating mid-to-late stage solid tumors. The founding team from Harvard University, Peking University and University of Tokyo, has successfully completed three rounds of equity financing. We have a clinical-stage pipeline (Tumor Reactive T Cells against solid tumor) and an immune cell rejuvenation platform, both of which we are actively seeking collaborations for.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}